Clinical Trial Update: Practicability and Acceptability of Stylomax® in Children [Phase 3]

View source ↗

Summary

A completed Phase 3 clinical trial evaluating the practicability and acceptability of Stylomax in children with growth hormone deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Stylomax (somatropin)

Snippet

Sponsor: Sanofi | Conditions: Growth Hormone Deficiency | Phase 3 | Status: COMPLETED